{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:08:59Z","timestamp":1789560539610,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.juro.2013.09.014","type":"journal-article","created":{"date-parts":[[2013,9,14]],"date-time":"2013-09-14T14:47:54Z","timestamp":1379170074000},"page":"502-509","source":"Crossref","is-referenced-by-count":21,"title":["Emetine Dihydrochloride: A Novel Therapy for Bladder Cancer"],"prefix":"10.1097","volume":"191","author":[{"given":"Kimberly E.","family":"Foreman","sequence":"first","affiliation":[{"name":"Department of Pathology, Loyola University Chicago, Maywood, Illinois"},{"name":"Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois"},{"name":"Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Jesse","sequence":"additional","affiliation":[{"name":"Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Surgery, Loyola University Chicago, Maywood, Illinois"},{"name":"Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois"},{"name":"Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gopal N.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Department of Surgery, Loyola University Chicago, Maywood, Illinois"},{"name":"Department of Urology, Loyola University Chicago, Maywood, Illinois"},{"name":"Stritch School of Medicine, Loyola University Chicago, Maywood, Illinois"},{"name":"Oncology Institute, Cardinal Bernardin Cancer Center, Loyola University Chicago, Maywood, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.09.014_bib1","series-title":"Cancer Facts and Figures 2013","year":"2013"},{"key":"10.1016\/j.juro.2013.09.014_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0022-5347(01)62067-6","article-title":"The impact of primary stage on survival in patients with lymph node positive bladder cancer","volume":"161","author":"Vieweg","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2013.09.014_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1874848101104010008","article-title":"Biological activities of emetine","volume":"4","author":"Akinboye","year":"2011","journal-title":"Open Natural Products J"},{"key":"10.1016\/j.juro.2013.09.014_bib4","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1002\/1097-0142(197104)27:4<835::AID-CNCR2820270413>3.0.CO;2-K","article-title":"Experience with emetine hydrochloride (NSC 33669) as an antitumor agent","volume":"27","author":"Panettiere","year":"1971","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2013.09.014_bib5","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1002\/1097-0142(197305)31:5<1170::AID-CNCR2820310520>3.0.CO;2-4","article-title":"A\u00a0phase I study of emetine hydrochloride (NSC\u00a033669) in solid tumors","volume":"31","author":"Mastrangelo","year":"1973","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2013.09.014_bib6","first-page":"1171","article-title":"Phase I-II evaluation of emetine (NSC-33669) in the treatment of epidermoid bronchogenic carcinoma","volume":"59","author":"Kane","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.juro.2013.09.014_bib7","first-page":"423","article-title":"Phase II study of\u00a0emetine (NSC-33669) in the treatment of solid\u00a0tumors","volume":"57","author":"Siddiqui","year":"1973","journal-title":"Cancer Chemother Rep"},{"key":"10.1016\/j.juro.2013.09.014_bib8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1055\/s-2006-941546","article-title":"Reduction of cytotoxicity of the alkaloid emetine through P-glycoprotein (MDR1\/ABCB1) in human Caco-2 cells and leukemia cell lines","volume":"72","author":"M\u00f6ller","year":"2006","journal-title":"Planta Med"},{"key":"10.1016\/j.juro.2013.09.014_bib9","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1055\/s-2007-990229","article-title":"Characteristics of apoptosis induction by the alkaloid emetine in human tumour cell lines","volume":"73","author":"M\u00f6ller","year":"2007","journal-title":"Planta Med"},{"key":"10.1016\/j.juro.2013.09.014_bib10","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1242\/jcs.107.9.2483","article-title":"Formation of high molecular mass DNA fragments is a marker of apoptosis in the human leukaemic cell line, U937","volume":"107","author":"Bicknell","year":"1994","journal-title":"J Cell Sci"},{"key":"10.1016\/j.juro.2013.09.014_bib11","first-page":"737","article-title":"The alkaloid emetine as a promising agent for the induction and enhancement of drug-induced apoptosis in leukemia cells","volume":"18","author":"M\u00f6ller","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.juro.2013.09.014_bib12","first-page":"287","article-title":"Chemotherapy of neoplasia (cancer) with dehydroemetine","volume":"72","author":"Abd-Rabbo","year":"1969","journal-title":"J Trop Med Hyg"},{"key":"10.1016\/j.juro.2013.09.014_bib13","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and\u00a0antagonism in drug combination studies","volume":"58","author":"Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.juro.2013.09.014_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.09.014_bib15","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/clim.1999.4712","article-title":"Expression of costimulatory molecules CD80 and\/or CD86 by a Kaposi\u2019s sarcoma tumor cell line induces differential T-cell activation and proliferation","volume":"91","author":"Foreman","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.juro.2013.09.014_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(72)91771-0","article-title":"Cyclophosphamide plus emetine in lung cancer","volume":"2","author":"Street","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2013.09.014_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00280-009-0997-6","article-title":"Combination analyses of anti-cancer drugs on human neuroendocrine tumor cell lines","volume":"65","author":"Larsson","year":"2009","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.juro.2013.09.014_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0092-8674(77)90140-4","article-title":"The molecular basis of emetine resistance in Chinese hamster ovary cells: alteration in the 40S ribosomal subunit","volume":"10","author":"Gupta","year":"1977","journal-title":"Cell"},{"key":"10.1016\/j.juro.2013.09.014_bib19","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1021\/bi00640a030","article-title":"Enzymic and nonenzymic translocation by yeast polysomes. Site of action of a number of inhibitors","volume":"16","author":"Jimenez","year":"1977","journal-title":"Biochemistry"},{"key":"10.1016\/j.juro.2013.09.014_bib20","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1016\/S0021-9258(18)93283-7","article-title":"Inhibitors of protein biosynthesis. V. Effects of emetine on protein and nucleic acid biosynthesis in HeLa cells","volume":"243","author":"Grollman","year":"1968","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2013.09.014_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1124\/mol.110.066514","article-title":"Emetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2alpha in clear cell renal carcinoma","volume":"78","author":"Kong","year":"2010","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.juro.2013.09.014_bib22","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1021\/np050029m","article-title":"Terpenoid tetrahydroisoquinoline alkaloids emetine, klugine, and isocephaeline inhibit the activation of hypoxia-inducible factor-1 in breast tumor cells","volume":"68","author":"Zhou","year":"2005","journal-title":"J Nat Prod"},{"key":"10.1016\/j.juro.2013.09.014_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.bcp.2009.12.021","article-title":"Identification of known drugs that act as inhibitors of NF-kappaB signaling and their mechanism of action","volume":"79","author":"Miller","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.juro.2013.09.014_bib24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/BF02888038","article-title":"Expression of multidrug-associated protein, P-glycoprotein, P53 and Bcl-2 proteins in bladder cancer and clinical implication","volume":"21","author":"Chen","year":"2001","journal-title":"J Tongji Med Univ"},{"key":"10.1016\/j.juro.2013.09.014_bib25","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1097\/01.ju.0000074710.96154.c9","volume":"170","author":"Diestra","year":"2003","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713054438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534713054438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.09.014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:34:35Z","timestamp":1651203275000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.09.014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["10.1016\/j.juro.2013.09.014"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.09.014","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}